Clinical trial
Integrating Buprenorphine Into HIV Treatment
NCT00241930 · Organization to Achieve Solutions in Substance Abuse (OASIS), Other · Unknown status
Key facts
| NCT number | NCT00241930 |
|---|---|
| Title | Integrating Buprenorphine Into HIV Treatment |
| Official title | SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model |
| Lead sponsor | Organization to Achieve Solutions in Substance Abuse (OASIS), Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Opiate Dependence, HIV Infections |
| Intervention type | Behavioral |
| Interventions | Integrating drug treatment into HIV services |
| Enrollment | 60 |
| Start date | Sep 1, 2005 |
| Completion | Feb 1, 2009 |
| First posted | Oct 19, 2005 |
| Last update posted | Oct 25, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: